Dr. Thomas Schmittgen is identifying novel treatments and new ways to deliver those therapies by restoring microRNA levels in cancer cells in hopes of finding options for people with the disease.
Thomson Reuters interviewed Lawrence Lesko, Ph.D., professor of pharmaceutics at the University of Florida College of Pharmacy. The story was featured in Thomson Reuters’ Research Highlight Series in the institution and government research section. …
Biosimulation in drug development and regulatory science served as the focus of the symposium.
The research talents of nearly 70 College of Pharmacy graduate and professional students and postdoctoral fellows were on display at the 29th Annual Research Showcase competition.
Stephan Schmidt, Ph.D., an assistant professor in the department of pharmaceutics, has been appointed as the vice chair of the Systems Pharmacology Community at the American Society for Clinical Pharmacology and Therapeutics, or ASCPT. In his role, he will lead efforts to develop a five-year strategic plan…
Dr. Hartmut Derendorf will serve as an ambassador of the University of Florida's academic and research achievements in his new alumni role.
Marcus Brewster, Nicholas Bodor and Hartmut Derendorf Graduate Research Professor Emeritus (active) Nicholas Bodor, Ph.D., D.Sc., was honored in February on his 75th birthday for more than 30 years of service to the UF College of Pharmacy. Bodor, executive director of the UF Center for Drug Discovery, joined…
Nicholas Bodor, Ph.D., D.Sc., Graduate Research Professor Emeritus (active) at the UF College of Pharmacy, in 2011, received high honors from his native country, Hungary in recognition of his global scientific accomplishments. In August, the Hungarian government recognized Bodor at its official ceremony in Budapest. Bodor received the Commander's Cross of the Order of Merit of the Hungarian Republic, a prestigious state award of civil merit. He received the cross at an official ceremony in the Hungarian parliament on the eve of the August 20th national celebration of Hungary's canonized first king, St. Stephen. Bodor also received the complemental pin, the Knight's Cross of the Order of Merit and an ornate diploma summarizing his accomplishments. Previously, in 2004, he received the Gold Cross of Merit of the Hungarian Republic.
A leading scientist in clinical pharmacology at the Food and Drug Administration is taking a new academic role at the University of Florida College of Pharmacy to improve drug development and create tools and approaches to make sure new products are safe, effective and within FDA-regulated standards. Lawrence J. Lesko, Ph.D., director of the Office of Clinical Pharmacology at the FDA’s Center for Drug Evaluation and Research, will lead the college’s new pharmacometrics and systems pharmacology initiative in the interdisciplinary Institute of Therapeutic Innovation at the UF Research and Academic Center, now under construction in Orlando.
The process of bringing one new drug to market can take a decade and hundreds of millions of dollars. Hartmut Derendorf, a distinguished professor in the UF College of Pharmacy, is finding ways to tighten expenses and shorten timelines while balancing patient variability, drug safety and effectiveness against all possible risks. His work was recognized by two national pharmacy organizations this year. In July he received the 2010 Volwiler Research Achievement Award from the American Association of Colleges of Pharmacy at its annual meeting in Seattle. “Dr. Derendorf is an exceptional leader and teacher. He is not only known for his incredible contributions to pharmaceutical education, but for his leadership and mentorship to advance research that is vital to the academic community,” said Lucinda L. Maine, Ph.D., R.Ph., AACP executive vice president and CEO, when she presented the award.